3C
NPTN

361 Capital’s NEOPHOTONICS CORP NPTN Stock Holding History

361 Capital’s Portfolio NPTN Stock Details NPTN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		$639K Buy
+71,946
New +$620K 0.3% 184

Other funds holding NPTN

Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

361 Capital's NPTN Position: Q2 2020 in Review

361 Capital opened a new position in NEOPHOTONICS CORP (NPTN) in Q2 2020: 71,946 shares worth $639K. The stake represents 0.3% of the portfolio and ranks #184 among its holdings.

163 funds tracked by Wall St. Rank hold NPTN as of Q2 2020.

  • 361 Capital held 71,946 shares of NEOPHOTONICS CORP worth $639K as of Q2 2020.
  • NEOPHOTONICS CORP was a new 361 Capital position in Q2 2020.
  • NEOPHOTONICS CORP made up 0.3% of 361 Capital's portfolio in Q2 2020, its #184 holding.
  • 163 funds tracked by Wall St. Rank held NEOPHOTONICS CORP as of Q2 2020.

Based on 361 Capital's 13F filing for Q2 2020, filed 14 Aug 2020.